Study of Decitabine and Tetrahydrouridine (THU) in Patients With Sickle Cell Disease

NCT01685515 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Sickle Cell Disease

Interventions

DRUG: Oral Decitabine and Tetrahydrouridine
DRUG: Placebo

Sponsor

Yogen Saunthararajah

Collaborators

[object Object]